Soleus Capital Management, L.P. Compass Pathways PLC Transaction History

Soleus Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	N/A	-399,000 Reduced 41.37%	565,550 $4.83 Million
Q3 2023 Nov 14, 2023	BUY	N/A	964,550 New	964,550 $8.24 Million
Q4 2021 Feb 14, 2022	SELL	$21.81 - $48.96 $2.79 Million - $6.25 Million	-127,743 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.29 - $39.68 $2.74 Million - $3.37 Million	85,000 Added 198.86%	127,743 $4.87 Million
Q4 2020 Feb 16, 2021	SELL	$32.0 - $59.2 $3.66 Million - $6.76 Million	-114,239 Reduced 72.77%	42,743 $2.04 Million
Q3 2020 Nov 13, 2020	BUY	$28.83 - $43.17 $4.53 Million - $6.78 Million	156,982 New	156,982 $5.48 Million

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.